# Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs

> **NCT03630692** · — · UNKNOWN · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 158 (estimated)

## Conditions studied

- Metastatic Renal Cancer
- Stage III Renal Cell Cancer

## Interventions

- **DRUG:** observance of oral drug treatment

## Key facts

- **NCT ID:** NCT03630692
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03-25
- **Primary completion:** 2020-01
- **Final completion:** 2020-06
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2018-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03630692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03630692, "Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03630692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*